PRAC recommends new measures to avoid valproate exposure in pregnancy
The European Medicines Agency’s experts in medicines safety, the Pharmacovigilance Risk Assessment Committee (PRAC) are recommending new measures to avoid exposure of babies to valproate medicines in the womb. Babies exposed are at risk of malformations and developmental problems. The PRAC examined the available evidence and consulted widely with healthcare professionals and with patients, including women […]
PRAC recommends new measures to avoid valproate exposure in pregnancy Read More »